Factors influencing intent to receive COVID-19 vaccination among Black and White adults in the southeastern United States, October - December 2020.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
02 12 2021
Historique:
pubmed: 2 12 2021
medline: 3 3 2022
entrez: 1 12 2021
Statut: ppublish

Résumé

Vaccination intent is foundational for effective COVID-19 vaccine campaigns. To understand factors and attitudes influencing COVID-19 vaccination intent in Black and White adults in the US south, we conducted a mixed-methods cross-sectional survey of 4512 adults enrolled in the Southern Community Cohort Study (SCCS), an ongoing study of racial and economic health disparities. Vaccination intent was measured as "If a vaccine to prevent COVID-19 became available to you, how likely are you to choose to get the COVID-19 vaccination?" with options of "very unlikely," "somewhat unlikely," "neither unlikely nor likely," "somewhat likely," and "very likely." Reasons for intent, socio-demographic factors, preventive behaviors, and other factors were collected. 46% of participants had uncertain or low intent. Lower intent was associated with female gender, younger age, Black race, more spiritual/religious, lower perceived COVID-19 susceptibility, living in a greater deprivation area, lower reading ability, and lack of confidence in childhood vaccine safety or COVID-19 vaccine effectiveness or safety (

Identifiants

pubmed: 34847822
doi: 10.1080/21645515.2021.1984134
pmc: PMC8903908
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

4761-4798

Subventions

Organisme : NCI NIH HHS
ID : P30 CA068485
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA202979
Pays : United States

Références

J Natl Med Assoc. 2005 Jul;97(7):972-9
pubmed: 16080667
Ann Intern Med. 2020 Dec 15;173(12):964-973
pubmed: 32886525
J Relig Health. 2021 Feb;60(1):65-80
pubmed: 33125543
MMWR Morb Mortal Wkly Rep. 2021 Feb 12;70(6):217-222
pubmed: 33571174
Am J Infect Control. 2021 Feb;49(2):137-142
pubmed: 33227323
J Health Care Poor Underserved. 2010 Aug;21(3):879-97
pubmed: 20693733
Vaccine. 2019 Feb 21;37(9):1168-1173
pubmed: 30709722
Am J Infect Control. 2015 Nov;43(11):1161-5
pubmed: 26521933
J Relig Health. 2016 Apr;55(2):403-21
pubmed: 26613589
MMWR Morb Mortal Wkly Rep. 2021 Apr 02;70(13):473-477
pubmed: 33793457
J Gen Intern Med. 1999 Sep;14(9):537-46
pubmed: 10491242
PLoS Curr. 2016 Dec 29;8:
pubmed: 28239512
Annu Rev Sociol. 2010 Aug;36:349-370
pubmed: 21909182
Soc Sci Med. 2021 Mar;272:113688
pubmed: 33485215
Vaccines (Basel). 2020 Oct 03;8(4):
pubmed: 33022917
PLoS One. 2021 Feb 16;16(2):e0246970
pubmed: 33592035
Environ Health Perspect. 2021 Jan;129(1):17701
pubmed: 33400596
J Racial Ethn Health Disparities. 2021 Aug;8(4):927-942
pubmed: 33215358
J Health Care Poor Underserved. 2010 Feb;21(1 Suppl):26-37
pubmed: 20173283
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
N Engl J Med. 2018 Jun 28;378(26):2456-2458
pubmed: 29949490
J Community Health. 2021 Apr;46(2):270-277
pubmed: 33389421
MMWR Morb Mortal Wkly Rep. 2021 Mar 26;70(12):431-436
pubmed: 33764963

Auteurs

Jennifer Cunningham-Erves (J)

Department of Internal Medicine, Meharry Medical College, Nashville, TN, USA.

Carol S Mayer (CS)

Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.

Xijing Han (X)

Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.

Landon Fike (L)

School of Medicine, Vanderbilt University, Nashville, TN, USA.

Chang Yu (C)

Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.

Phyllis M Tousey (PM)

Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.

David G Schlundt (DG)

Department of Psychology, Vanderbilt University, Nashville, TN, USA.

Deepak K Gupta (DK)

Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Vanderbilt Translational and Clinical Cardiovascular Research Center, Vanderbilt University Medical Center, Nashville, TN, USA.

Michael T Mumma (MT)

Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.

David Walkley (D)

Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.

Mark D Steinwandel (MD)

Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.

Kathryn M Edwards (KM)

School of Medicine, Vanderbilt University, Nashville, TN, USA.

Loren Lipworth (L)

Vanderbilt Translational and Clinical Cardiovascular Research Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Maureen Sanderson (M)

Department of Family and Community Medicine, Meharry Medical College, Nashville, TN, USA.

Xiao-Ou Shu (XO)

Vanderbilt Translational and Clinical Cardiovascular Research Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.

Martha J Shrubsole (MJ)

Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH